Answers are grounded in this paper and cite their sources.
This review discusses the current status of proteomics technology in endometrial cancer diagnosis, treatment and prognosis. The first part of this review focuses on recently identified biomarkers for endometrial cancer, their importance in clinical use as well as the proteomic methods used in their discovery. The second part highlights some of the emerging mass spectrometry based proteomic technologies that promise to contribute to a better understanding of endometrial cancer by comparing the abundance of hundreds or thousands of proteins simultaneously.
No takes yet. Share an insight, caveat, or question.
Mittal et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: